Skip to main content
Livermore
Livermore
ZHEN

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

PCVX holding history

Vaxcyte, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCVX overviewAll 13F holders of PCVXFull Q2 2026 holdings

Shares (Q2 2026)
26,740
Value
$1.55M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of PCVX by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202626,740$1.55M<0.1%−5,472−17.0%ReducedHolders
Q1 202632,212$1.87M<0.1%+11,783+57.7%AddedHolders
Q4 202520,429$943.0K<0.1%−5,129−20.1%ReducedHolders
Q3 202525,558$921.0K<0.1%+14,421+129.5%AddedHolders
Q2 202511,137$362.0K<0.1%−3,383−23.3%ReducedHolders
Q1 202514,520$548.0K<0.1%+5,520+61.3%AddedHolders
Q4 20249,000$737.0K<0.1%−530−5.6%ReducedHolders
Q3 20249,530$1.09M<0.1%+7,188+306.9%AddedHolders
Q2 20242,342$177.0K<0.1%−2,017−46.3%ReducedHolders
Q1 20244,359$298.0K<0.1%+4,359NewHolders
Q4 20230$00.0%−27,980−100.0%Sold outHolders
Q3 202327,980$1.43M<0.1%+27,980NewHolders
Q2 20230$00.0%−50,626−100.0%Sold outHolders
Q1 202350,626$1.90M<0.1%+23,256+85.0%AddedHolders
Q4 202227,370$1.31M<0.1%+12,098+79.2%AddedHolders
Q3 202215,272$367.0K<0.1%−1,073−6.6%ReducedHolders
Q2 202216,345$356.0K<0.1%+16,345NewHolders
Q1 20220$00.0%−10,155−100.0%Sold outHolders
Q4 202110,155$242.0K<0.1%−15,515−60.4%ReducedHolders
Q3 202125,670$651.0K<0.1%+25,670NewHolders
Q2 20210$00.0%−6,714−100.0%Sold outHolders
Q1 20216,714$133.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.